# General Electric Co: financial statements, quarterly GE · NYSE · CIK 40545 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ge.md) · [Financials](/companies/ge/financials.md) · [Filings](/companies/ge/filings.md) · [Insiders](/companies/ge/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ge/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [8.5](/filings/0000040545-25-000015.md) | [8.1](/filings/0000040545-25-000015.md) | [8.2](/filings/0000040545-25-000015.md) | [8.9](/filings/0000040545-25-000015.md) | [9.9](/filings/0000040545-25-000015.md) | [9.9](/filings/0000040545-26-000027.md) | [11.0](/filings/0000040545-26-000049.md) | [12.2](/filings/0000040545-26-000064.md) | [12.7 d](/filings/0000040545-26-000008.md) | [12.4](/filings/0000040545-26-000027.md) | [13.3](/filings/0000040545-26-000049.md) | [14.1](/filings/0000040545-26-000064.md) | | Cost of revenue | $bn | [6.3](/filings/0000040545-25-000015.md) | [5.7](/filings/0000040545-25-000015.md) | [5.6](/filings/0000040545-25-000015.md) | [6.2](/filings/0000040545-25-000015.md) | [6.8](/filings/0000040545-25-000015.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Research and development | $bn | [0.3 d](/filings/0000040545-26-000008.md) | [0.3](/filings/0000040545-25-000062.md) | [0.3](/filings/0000040545-25-000111.md) | [0.3](/filings/0000040545-25-000132.md) | [0.4 d](/filings/0000040545-26-000008.md) | [0.4](/filings/0000040545-26-000027.md) | [0.4](/filings/0000040545-26-000049.md) | [0.4](/filings/0000040545-26-000064.md) | [0.4 d](/filings/0000040545-26-000008.md) | [0.4](/filings/0000040545-26-000027.md) | [0.5](/filings/0000040545-26-000049.md) | [0.5](/filings/0000040545-26-000064.md) | | Selling, general and administrative | $bn | [1.2 d](/filings/0000040545-26-000008.md) | [1.0](/filings/0000040545-25-000062.md) | [0.9](/filings/0000040545-25-000111.md) | [1.3](/filings/0000040545-25-000132.md) | [1.2 d](/filings/0000040545-26-000008.md) | [0.9](/filings/0000040545-26-000027.md) | [1.0](/filings/0000040545-26-000049.md) | [1.2](/filings/0000040545-26-000064.md) | [1.0 d](/filings/0000040545-26-000008.md) | [1.1](/filings/0000040545-26-000027.md) | [1.1](/filings/0000040545-26-000049.md) | [1.1](/filings/0000040545-26-000064.md) | | Operating income | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $bn | [0.5 d](/filings/0000040545-26-000008.md) | [0.2](/filings/0000040545-25-000062.md) | [0.1](/filings/0000040545-25-000111.md) | [0.2](/filings/0000040545-25-000132.md) | [0.4 d](/filings/0000040545-26-000008.md) | [0.3](/filings/0000040545-26-000027.md) | [0.4](/filings/0000040545-26-000049.md) | [0.3](/filings/0000040545-26-000064.md) | [0.4 d](/filings/0000040545-26-000008.md) | [0.3](/filings/0000040545-26-000027.md) | [0.4](/filings/0000040545-26-000049.md) | [0.4](/filings/0000040545-26-000064.md) | | Net income | $bn | [1.6](/filings/0000040545-25-000015.md) | [1.5](/filings/0000040545-25-000062.md) | [1.3](/filings/0000040545-25-000111.md) | [1.9](/filings/0000040545-25-000132.md) | [1.9](/filings/0000040545-25-000015.md) | [2.0](/filings/0000040545-26-000027.md) | [2.0](/filings/0000040545-26-000049.md) | [2.2](/filings/0000040545-26-000064.md) | [2.5 d](/filings/0000040545-26-000008.md) | [1.9](/filings/0000040545-26-000027.md) | [2.4](/filings/0000040545-26-000049.md) | [2.3](/filings/0000040545-26-000064.md) | | Diluted EPS | $ per share | [1.44](/filings/0000040545-25-000015.md) | [1.40](/filings/0000040545-25-000062.md) | [1.15](/filings/0000040545-25-000111.md) | [1.70](/filings/0000040545-25-000132.md) | [1.75](/filings/0000040545-25-000015.md) | [1.83](/filings/0000040545-26-000027.md) | [1.89](/filings/0000040545-26-000049.md) | [2.02](/filings/0000040545-26-000064.md) | not reported | [1.81](/filings/0000040545-26-000027.md) | [2.26](/filings/0000040545-26-000049.md) | [2.20](/filings/0000040545-26-000064.md) | | Basic EPS | $ per share | [1.46](/filings/0000040545-25-000015.md) | [1.41](/filings/0000040545-25-000062.md) | [1.16](/filings/0000040545-25-000111.md) | [1.71](/filings/0000040545-25-000132.md) | [1.76](/filings/0000040545-25-000015.md) | [1.85](/filings/0000040545-26-000027.md) | [1.91](/filings/0000040545-26-000049.md) | [2.04](/filings/0000040545-26-000064.md) | not reported | [1.82](/filings/0000040545-26-000027.md) | [2.28](/filings/0000040545-26-000049.md) | [2.21](/filings/0000040545-26-000064.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: not reported - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current assets | $bn | [42.6](/filings/0000040545-25-000015.md) | [59.6](/filings/0000040545-24-000113.md) | [37.4](/filings/0000040545-24-000176.md) | [38.6](/filings/0000040545-24-000200.md) | [37.6](/filings/0000040545-26-000008.md) | [37.6](/filings/0000040545-25-000062.md) | [37.8](/filings/0000040545-25-000111.md) | [40.1](/filings/0000040545-25-000132.md) | [40.6](/filings/0000040545-26-000064.md) | [40.4](/filings/0000040545-26-000027.md) | [39.7](/filings/0000040545-26-000049.md) | [41.5](/filings/0000040545-26-000064.md) | | Total assets | $bn | [173](/filings/0000040545-25-000015.md) | [164](/filings/0000040545-24-000113.md) | [123](/filings/0000040545-24-000176.md) | [127](/filings/0000040545-24-000200.md) | [123](/filings/0000040545-26-000008.md) | [124](/filings/0000040545-25-000062.md) | [125](/filings/0000040545-25-000111.md) | [128](/filings/0000040545-25-000132.md) | [130](/filings/0000040545-26-000064.md) | [128](/filings/0000040545-26-000027.md) | [128](/filings/0000040545-26-000049.md) | [127](/filings/0000040545-26-000064.md) | | Current liabilities | $bn | [32.1](/filings/0000040545-25-000015.md) | [51.1](/filings/0000040545-24-000113.md) | [32.8](/filings/0000040545-24-000176.md) | [34.1](/filings/0000040545-24-000200.md) | [34.4](/filings/0000040545-26-000008.md) | [34.9](/filings/0000040545-25-000062.md) | [36.5](/filings/0000040545-25-000111.md) | [37.2](/filings/0000040545-25-000132.md) | [39.0](/filings/0000040545-26-000064.md) | [40.0](/filings/0000040545-26-000027.md) | [40.4](/filings/0000040545-26-000049.md) | [42.4](/filings/0000040545-26-000064.md) | | Total liabilities | $bn | [145](/filings/0000040545-25-000015.md) | [133](/filings/0000040545-24-000113.md) | [104](/filings/0000040545-24-000176.md) | [108](/filings/0000040545-24-000200.md) | [104](/filings/0000040545-26-000008.md) | [105](/filings/0000040545-25-000062.md) | [106](/filings/0000040545-25-000111.md) | [109](/filings/0000040545-25-000132.md) | [111](/filings/0000040545-26-000064.md) | [110](/filings/0000040545-26-000027.md) | [110](/filings/0000040545-26-000049.md) | [109](/filings/0000040545-26-000064.md) | | Long-term debt | $bn | [20.9](/filings/0000040545-24-000027.md) | not reported | not reported | not reported | [19.3](/filings/0000040545-25-000015.md) | not reported | not reported | not reported | [20.5](/filings/0000040545-26-000008.md) | not reported | not reported | not reported | | Current portion of debt | $bn | [1.1](/filings/0000040545-25-000015.md) | [1.0](/filings/0000040545-24-000113.md) | [1.7](/filings/0000040545-24-000176.md) | [1.7](/filings/0000040545-24-000200.md) | [2.0](/filings/0000040545-26-000008.md) | [2.1](/filings/0000040545-25-000062.md) | [1.9](/filings/0000040545-25-000111.md) | [2.1](/filings/0000040545-25-000132.md) | [1.7](/filings/0000040545-26-000064.md) | [2.1](/filings/0000040545-26-000027.md) | [2.0](/filings/0000040545-26-000049.md) | [2.3](/filings/0000040545-26-000064.md) | | Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0000040545-26-000008.md) | not reported | [0.0](/filings/0000040545-25-000111.md) | [0.0](/filings/0000040545-25-000132.md) | [0.0](/filings/0000040545-26-000049.md) | [0.0](/filings/0000040545-26-000027.md) | [0.0](/filings/0000040545-26-000049.md) | [0.5](/filings/0000040545-26-000064.md) | | Shareholders' equity | $bn | [27.4](/filings/0000040545-25-000015.md) | [29.9](/filings/0000040545-24-000113.md) | [18.6](/filings/0000040545-24-000176.md) | [18.9](/filings/0000040545-24-000200.md) | [19.3](/filings/0000040545-26-000008.md) | [19.3](/filings/0000040545-25-000062.md) | [19.1](/filings/0000040545-25-000111.md) | [18.8](/filings/0000040545-25-000132.md) | [18.7](/filings/0000040545-26-000064.md) | [18.1](/filings/0000040545-26-000027.md) | [17.6](/filings/0000040545-26-000049.md) | [17.5](/filings/0000040545-26-000064.md) | - Cash and equivalents: not reported - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings, us-gaap:CommercialPaper - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [3,140 d](/filings/0000040545-26-000008.md) | [994](/filings/0000040545-25-000062.md) | [911 d](/filings/0000040545-25-000111.md) | [1,508 d](/filings/0000040545-25-000132.md) | [1,297 d](/filings/0000040545-26-000008.md) | [1,509](/filings/0000040545-26-000027.md) | [2,246 d](/filings/0000040545-26-000049.md) | [2,501 d](/filings/0000040545-26-000064.md) | [2,281 d](/filings/0000040545-26-000008.md) | [1,823](/filings/0000040545-26-000027.md) | [3,195 d](/filings/0000040545-26-000049.md) | [2,152 d](/filings/0000040545-26-000064.md) | | Capital expenditure | $m | [250 d](/filings/0000040545-26-000008.md) | [204](/filings/0000040545-25-000062.md) | [295 d](/filings/0000040545-25-000111.md) | [266 d](/filings/0000040545-25-000132.md) | [267 d](/filings/0000040545-26-000008.md) | [208](/filings/0000040545-26-000027.md) | [327 d](/filings/0000040545-26-000049.md) | [307 d](/filings/0000040545-26-000064.md) | [431 d](/filings/0000040545-26-000008.md) | [331](/filings/0000040545-26-000027.md) | [335 d](/filings/0000040545-26-000049.md) | [336 d](/filings/0000040545-26-000064.md) | | Share repurchases | $m | [288 d](/filings/0000040545-26-000008.md) | [322](/filings/0000040545-25-000062.md) | [2,301 d](/filings/0000040545-25-000111.md) | [1,536 d](/filings/0000040545-25-000132.md) | [1,668 d](/filings/0000040545-26-000008.md) | [1,965](/filings/0000040545-26-000027.md) | [1,745 d](/filings/0000040545-26-000049.md) | [1,844 d](/filings/0000040545-26-000064.md) | [1,997 d](/filings/0000040545-26-000008.md) | [2,399](/filings/0000040545-26-000027.md) | [2,128 d](/filings/0000040545-26-000049.md) | [1,979 d](/filings/0000040545-26-000064.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [1,097](/filings/0000040545-24-000113.md) | [1,098](/filings/0000040545-24-000176.md) | [1,099](/filings/0000040545-24-000200.md) | [1,103](/filings/0000040545-25-000062.md) | [1,100](/filings/0000040545-25-000111.md) | [1,093](/filings/0000040545-25-000132.md) | [1,078](/filings/0000040545-26-000027.md) | [1,071](/filings/0000040545-26-000049.md) | [1,065](/filings/0000040545-26-000064.md) | [1,054](/filings/0000040545-26-000027.md) | [1,047](/filings/0000040545-26-000049.md) | [1,041](/filings/0000040545-26-000064.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 1,033,351,921 at 2026-09-30, from the cover of the [10-Q filed 2026-10-20](/filings/0000040545-26-000064.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.